WCLC roundup: AstraZeneca, Amgen, J&J and Hutchmed tout new combination or confirmatory data
The World Congress on Lung Cancer took place this year from Sept. 9-12 in Singapore. Endpoints News bought you breaking coverage of key data releases at the event, from a first glimpse at the activity of novel TROP2-directed candidates to add-ons to tried and tested treatments in lung cancer. Now, we’ve rounded up a quartet of early-to-mid-stage and confirmatory results also presented at the WCLC.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.